Zydus Faces Rs 1.18 Crore GST Blow as Appellate Authority Upholds Tax Demand, Penalty

Written By :  Parthika Patel
Published On 2026-05-15 16:59 GMT   |   Update On 2026-05-15 16:59 GMT
Advertisement

New Delhi: Zydus Lifesciences has said that the Appellate Authority of the Central Goods and Services Tax Appeals Commissionerate, Chandigarh, has upheld a GST demand and penalty order against the company related to alleged wrongful input tax credit claims.

The appeal order pertains to a demand of Rs 1.71 million and a penalty of Rs 10.12 million for the period between July 2017 and March 2021. The matter relates to various issues identified during a GST audit, according to the company’s regulatory filing.

Zydus Lifesciences stated that it had earlier challenged the original order before the appellate authority after receiving the demand order in January 2025. However, the appellate authority has now upheld both the demand and the penalty amount.

According to the company, the allegations relate to excess or wrongful input tax credit availed during the audit period. The order was received from the appellate authority on May 11, 2026.

As per the Zydus Lifesciences regulatory disclosure, the company plans to file a second appeal before the Goods and Services Tax Appellate Tribunal (GSTAT) against the latest order.

The company further clarified that the matter is not expected to have any material financial impact on its operations or overall business activities.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News